On-Demand Webinar: Reimagining clinical trials following Covid-19 disruption

Matt Bonam, Global Head, Biopharma R&D Digital Patient Health at AstraZeneca, and Calum MacRae, Vice Chair for Scientific Innovation, Department of Medicine at Brigham and Women’s Hospital, join our CEO, Bruce Hellman, to discuss the recovery and restart of clinical trials following the disruption caused by Covid-19.

Listen to recent insights and learnings from an investigator, sponsor, and technology perspective including the weaknesses in current trial design that the global pandemic has highlighted. And hear their thoughts on rather than digitising the old world and way of doing things how we can redesign new trials in the future.

Click here to watch this on-demand webinar.